TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BB Biotech ( (CH:BION) ) just unveiled an announcement.
BB Biotech AG’s General Meeting has approved all proposals from the Board of Directors, including a dividend of CHF 1.80 per share, to be paid on March 25, 2025. The re-election of the board members signifies stability and continuity in the company’s leadership, which is expected to positively impact its strategic investment decisions and maintain its strong position in the biotech investment sector.
More about BB Biotech
BB Biotech AG is an investment company based in Schaffhausen, Switzerland, and is listed on the Swiss and German stock exchanges. Since 1993, it has focused on investing in innovative drug development companies primarily located in the USA and Western Europe. The company is recognized as a leading investor in this sector, guided by an experienced Board of Directors and an Investment Management Team from Bellevue Asset Management AG.
YTD Price Performance: -0.50%
Average Trading Volume: 2,946
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: CHF1.93B
For an in-depth examination of BION stock, go to TipRanks’ Stock Analysis page.